PodParley PodParley
PodParley
HR-Positive and Triple-Negative Metastatic Breast Cancer | Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer episode artwork

EPISODE · Sep 6, 2024 · 1H 2M

HR-Positive and Triple-Negative Metastatic Breast Cancer | Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

from Research To Practice | Oncology Videos · host Dr. Neil Love

Featuring perspectives from Prof Peter Schmid and Dr Sara M Tolaney, including the following topics: Introduction: Pharmacology and Sequencing of Antibody-Drug Conjugates (ADCs) in Metastatic Breast Cancer (mBC) (0:00) Expanding Role of TROP2-Directed ADCs in mBC Management — Dr Tolaney (21:42) Other Targets for ADC Therapy in mBC — Prof Schmid (44:59) CME information and select publications

Episode metadata supplied by the publisher feed · Published Sep 6, 2024

Embed this episode

Ready to play

HR-Positive and Triple-Negative Metastatic Breast Cancer | Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer

0:00 1:02:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Research To Practice | Oncology Videos?

This episode is 1 hour and 2 minutes long.

When was this Research To Practice | Oncology Videos episode published?

This episode was published on September 6, 2024.

Can I download this Research To Practice | Oncology Videos episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!